Compare Stocks: IDN, CXDO, EGAN, and ZSQR

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CXDO Crexendo	$6.39 +1.6%	$7.16	$5.55 ▼ $11.23	$209.17M	1.12	404,498 shs	327,361 shs
EGAN eGain	$7.30 +0.6%	$6.88	$5.94 ▼ $15.95	$199.29M	0.81	106,587 shs	81,631 shs
IDN Intellicheck	$2.95	$3.83	$2.70 ▼ $9.08	$59.79M	0.81	477,677 shs	362,824 shs
ZSQR Coeptis Therapeutics	$3.65 -7.8%	$7.64	$3.61 ▼ $21.41	$209.88M	-0.2	353,450 shs	805,151 shs

The Best Nuclear Energy Stocks to Buy

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CXDO Crexendo	+1.59%	-3.91%	-14.34%	-33.51%	+7.94%
EGAN eGain	+0.55%	-2.67%	+13.53%	+4.29%	+20.86%
IDN Intellicheck	0.00%	+4.98%	-20.70%	-33.11%	-43.49%
ZSQR Coeptis Therapeutics	-7.83%	-7.36%	-26.71%	-59.35%	-73.18%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CXDO Crexendo	$6.39 +1.6%	$7.16	$5.55 ▼ $11.23	$209.17M	1.12	404,498 shs	327,361 shs
EGAN eGain	$7.30 +0.6%	$6.88	$5.94 ▼ $15.95	$199.29M	0.81	106,587 shs	81,631 shs
IDN Intellicheck	$2.95	$3.83	$2.70 ▼ $9.08	$59.79M	0.81	477,677 shs	362,824 shs
ZSQR Coeptis Therapeutics	$3.65 -7.8%	$7.64	$3.61 ▼ $21.41	$209.88M	-0.2	353,450 shs	805,151 shs

The Best Nuclear Energy Stocks to Buy

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CXDO Crexendo	+1.59%	-3.91%	-14.34%	-33.51%	+7.94%
EGAN eGain	+0.55%	-2.67%	+13.53%	+4.29%	+20.86%
IDN Intellicheck	0.00%	+4.98%	-20.70%	-33.11%	-43.49%
ZSQR Coeptis Therapeutics	-7.83%	-7.36%	-26.71%	-59.35%	-73.18%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CXDO Crexendo	2.75	Moderate Buy	$10.50	64.32% Upside
EGAN eGain	2.25	Hold	$15.25	108.90% Upside
IDN Intellicheck	2.50	Moderate Buy	$6.50	120.34% Upside
ZSQR Coeptis Therapeutics	1.00	Sell	N/A	N/A

Current Analyst Ratings Breakdown

Latest IDN, CXDO, EGAN, and ZSQR Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/14/2026	IDN Intellicheck	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C-) ➝ Hold (C)
8/14/2026	ZSQR Coeptis Therapeutics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E-)
8/14/2026	IDN Intellicheck	Northland Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$6.00
8/14/2026	IDN Intellicheck	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$7.50 ➝ $5.00
8/7/2026	EGAN eGain	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold (C)
8/5/2026	CXDO Crexendo	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$10.00 ➝ $9.00
8/3/2026	CXDO Crexendo	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold (C+)
7/13/2026	IDN Intellicheck	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
6/24/2026	IDN Intellicheck	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold (C) ➝ Hold (C-)
6/5/2026	IDN Intellicheck	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C-) ➝ Hold (C)

(Data available from 8/22/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CXDO Crexendo	$68.17M	3.12	$0.38 per share	16.82	$2.35 per share	2.72
EGAN eGain	$88.43M	2.27	$0.23 per share	32.33	$2.95 per share	2.47
IDN Intellicheck	$24.11M	2.48	$0.10 per share	30.16	$1.11 per share	2.66
ZSQR Coeptis Therapeutics	$1.36M	142.24	N/A	N/A	$2.50 per share	1.46

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CXDO Crexendo	$5.07M	$0.14	45.64	17.27	N/A	5.31%	14.34%	11.44%	11/3/2026 (Estimated)
EGAN eGain	$32.25M	$1.38	5.29	24.33	N/A	41.68%	12.56%	7.48%	9/3/2026 (Estimated)
IDN Intellicheck	$1.27M	$0.15	19.67	29.50	N/A	13.03%	15.02%	12.27%	N/A
ZSQR Coeptis Therapeutics	-$11.92M	-$1.63	N/A	N/A	N/A	-773.72%	-49.45%	-46.88%	N/A

Latest IDN, CXDO, EGAN, and ZSQR Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
9/3/2026	Q4 2026	EGAN eGain	$0.04	N/A	N/A	N/A	$21.75 million	N/A
8/13/2026	Q2 2026	IDN Intellicheck	$0.03	$0.03	N/A	$0.03	N/A	$5.94 million
8/13/2026	Q2 2026	ZSQR Coeptis Therapeutics	N/A	-$0.28	N/A	-$0.28	N/A	N/A
8/4/2026	Q2 2026	CXDO Crexendo	$0.0967	$0.12	+$0.0233	$0.03	$24.65 million	$24.65 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CXDO Crexendo	N/A	N/A	N/A	N/A	N/A
EGAN eGain	N/A	N/A	N/A	N/A	N/A
IDN Intellicheck	N/A	N/A	N/A	N/A	N/A
ZSQR Coeptis Therapeutics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CXDO Crexendo	0.06	2.06	1.98
EGAN eGain	N/A	2.15	2.15
IDN Intellicheck	N/A	4.98	4.98
ZSQR Coeptis Therapeutics	N/A	7.66	7.66

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CXDO Crexendo	9.53%
EGAN eGain	53.94%
IDN Intellicheck	42.79%
ZSQR Coeptis Therapeutics	13.88%

Insider Ownership

Company	Insider Ownership
CXDO Crexendo	47.20%
EGAN eGain	38.70%
IDN Intellicheck	7.76%
ZSQR Coeptis Therapeutics	24.25%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CXDO Crexendo	120	33.25 million	17.56 million	Optionable
EGAN eGain	690	27.45 million	16.83 million	Optionable
IDN Intellicheck	50	20.27 million	18.69 million	N/A
ZSQR Coeptis Therapeutics	2	53.00 million	40.15 million	Not Optionable

IDN, CXDO, EGAN, and ZSQR Headlines

Recent News About These Companies

Z Squared CEO to Shareholders: "The Scarcest Thing in AI is Not Chips. It is Power.

August 14, 2026 | prnewswire.com

Coeptis Therapeutics (NASDAQ:ZSQR) Issues Quarterly Earnings Results

August 13, 2026 | marketbeat.com

Z Squared Inc. Signs Definitive Agreement to Acquire 100% of Paradox Data and Its Union County Campus

August 3, 2026 | prnewswire.com

Short Interest in Coeptis Therapeutics Holdings, Inc. (NASDAQ:ZSQR) Expands By 120.7%

July 28, 2026 | marketbeat.com

Z Squared Inc. Terminates At-The-Market Sales Agreement and Committed Equity Forward Purchase Agreement

July 17, 2026 | prnewswire.com

Z Squared Inc. Provides Capital Structure Update

July 15, 2026 | prnewswire.com

Z Squared Inc. Appoints Jeffrey Harris as Chief Technology Officer

June 30, 2026 | prnewswire.com

Z Squared Raises Approximately $15.3 Million in Non-Debt Capital to Advance AI Infrastructure Strategy

June 29, 2026 | prnewswire.com

Russell Indexes Add Z Squared Inc. to Russell 2000® and Russell 3000®

June 29, 2026 | prnewswire.com

Z Squared, Inc. to Acquire Majority Interest in Paradox Data and Its Union County Campus, a Next-Generation Data Center Development Targeting Up to 150 MW of Firm Power

June 25, 2026 | prnewswire.com

Z Squared to Participate in Maxim Group's AI Data Center Summit

June 9, 2026 | prnewswire.com

Z Squared, Inc. Enters $50 Million Committed Equity Forward Purchase Agreement to Support AI Infrastructure Buildout

June 4, 2026 | prnewswire.com

Z Squared, Inc. Announces Preliminary Inclusion in Russell 3000® and Russell 2000® Indexes

May 27, 2026 | prnewswire.com

Vanderbilt Report: Z Squared Locks In Zero-Cash, Zero-Debt Path to 42 MW of AI-Ready Power

May 26, 2026 | globenewswire.com

Z Squared, Inc. Outlines Phase 1 Plan to Reach 100 MW of AI-Ready Infrastructure for Inference Workloads

May 19, 2026 | prnewswire.com

Z Squared Appoints Jon Najarian, Pete Najarian, Marc LoPresti and Jay Zapata to Newly Formed Advisory Board

May 4, 2026 | prnewswire.com

Z Squared to Acquire Skycore Digital, Adding 24 MW of Energized AI Infrastructure with Expansion Path to 42 MW

April 29, 2026 | prnewswire.com

Z Squared, Inc. to Ring the Nasdaq Closing Bell in Celebration of Its Listing on the Nasdaq Global Market

April 28, 2026 | prnewswire.com

Coeptis Therapeutics Announces Approval of Z Squared Inc.'s Nasdaq Listing Application

April 27, 2026 | finanznachrichten.de

Z Squared Provides Additional Information on Previously Disclosed Pro Rata Distribution

April 27, 2026 | tmcnet.com

Coeptis Therapeutics Receives Shareholder Approval Towards Z Squared Merger

April 27, 2026 | finanznachrichten.de

New MarketBeat Followers Over Time

Media Sentiment Over Time

IDN, CXDO, EGAN, and ZSQR Company Descriptions

Crexendo NASDAQ:CXDO

$6.39 +0.10 (+1.59%)

As of 08/21/2026 04:00 PM Eastern

Crexendo, Inc. provides cloud communication platform and services, video collaboration, and managed IT services for businesses in the United States and internationally. It operates through two segments, Cloud Telecommunications Services and Software Solutions. The Cloud Telecommunications segment provides telecommunications services that transmit calls using Internet protocol (IP) or cloud technology, which converts voice signals into digital data packets for transmission over the Internet or cloud; and broadband Internet services, as well as develops end user portals for account and license management, and billing and customer support. This segment is also involved in the sale and lease of cloud telecommunications equipment. In addition, it offers hardware, software, and unified communication solutions for businesses using IP or cloud technology over high-speed internet connection through various devices and user interfaces, such as desktop phones and/or mobile, and desktop applications under the Crexendo brand name. The Software Solutions segment provides a suite of unified communications, collaboration, video conferencing, and contact center solutions. This segment also offers SNAPsolution, an IP-based platform; SNAPaccel, a software-as-a-service based software; subscription maintenance and support services; and professional services, including consulting, technical support, resident engineer, design, and installation services. The company was formerly known as iMergent, Inc. and changed its name to Crexendo, Inc. in May 2011. Crexendo, Inc. was incorporated in 1995 and is based in Tempe, Arizona.

eGain NASDAQ:EGAN

$7.30 +0.04 (+0.55%)

As of 08/21/2026 04:00 PM Eastern

eGain Corporation develops, licenses, implements, and supports customer service infrastructure software solutions in North America, Europe, the Middle East, Africa, and the Asia Pacific. It provides eGain Knowledge Hub, which helps businesses to centralize knowledge, policies, procedures, situational expertise, best-practices, while delivering guided, and personalized solutions to customers and agents; eGain Conversation Hub for digital-first, omnichannel interaction management within a modern, purpose-built desktop; and eGain Analytics Hub enables clients to measure, manage, and optimize omnichannel service operations and knowledge. The company also offers subscription services that provides customers with access to its software on a cloud-based platform; and professional services, such as consulting and implementation, training, and managed services. It serves customers in various industry sectors, including the financial services, telecommunications, retail, government, healthcare, and utilities. The company was incorporated in 1997 and is headquartered in Sunnyvale, California.

Intellicheck NASDAQ:IDN

$2.95 0.00 (0.00%)

As of 08/21/2026 04:00 PM Eastern

Intellicheck, Inc., a technology company, develops, integrates, and markets threat identification and identity authentication solutions for bank and retail fraud prevention, law enforcement threat identification, and mobile and handheld access control and security systems primarily in the United States. It provides identity systems products, including commercial identification products, such as Intellicheck Platform, an identity solution that checks whether an ID is valid, matches the ID to the person presenting it, and provides a risk score to determine the risk of doing business with that person; IDN-Portal that provides the ability to scan an ID using a mobile phone; IDN-Portal+ that uses a retail scanner to validate an ID, and get additional data for analytics and analysis; IDN-Direct that provides access to additional data and the ability to use the platform's Risk Score capability to help with decision-making; and Intellicheck mobile app, which provides the ability to login and scan an ID. The company also offers State Aware Software solution, which provides or restricts information that is electronically scanned from an ID based on the electronic reading laws according to the state in which the ID is scanned; data collection devices that enable its software applications to be used on a variety of commercially available credit card terminals, PDAs, tablets, laptops, desktops, mobile phones, and point-of-sale terminals; and instant credit application kiosk software applications. It serves government, military, and commercial markets. The company was formerly known as Intellicheck Mobilisa, Inc. and changed its name to Intellicheck, Inc. in May 2017. Intellicheck, Inc. was incorporated in 1994 and is headquartered in Melville, New York.

Coeptis Therapeutics NASDAQ:ZSQR

$3.65 -0.31 (-7.83%)

As of 08/21/2026 04:00 PM Eastern

Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company, develops cell therapy platforms for patients with cancer. Its product portfolio consists of CD38-GEAR-NK, a cell therapy for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; SNAP-CAR, a CAR T cell therapy platform co-administered with tagged, tumor-specific antibodies to potentially target different tumor types, including hematological malignancies and solid tumors; and CD38-Diagnostic, an in vitro screening tool to analyze if cancer patients might be appropriate candidates for anti-CD38 mAb therapy. The company also offers its drugs for acute myeloid leukemia and acute respiratory diseases. Coeptis Therapeutics Holdings, Inc. has co-development agreement Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson's Disease. The company was founded in 2017 and is headquartered in Wexford, Pennsylvania.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest IDN, CXDO, EGAN, and ZSQR Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest IDN, CXDO, EGAN, and ZSQR Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

IDN, CXDO, EGAN, and ZSQR Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

IDN, CXDO, EGAN, and ZSQR Company Descriptions

Crexendo NASDAQ:CXDO

eGain NASDAQ:EGAN

Intellicheck NASDAQ:IDN

Coeptis Therapeutics NASDAQ:ZSQR

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest IDN, CXDO, EGAN, and ZSQR Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest IDN, CXDO, EGAN, and ZSQR Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

IDN, CXDO, EGAN, and ZSQR Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

IDN, CXDO, EGAN, and ZSQR Company Descriptions

Crexendo NASDAQ:CXDO

eGain NASDAQ:EGAN

Intellicheck NASDAQ:IDN

Coeptis Therapeutics NASDAQ:ZSQR

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools